Christopher Powala

Direttore/Membro del Consiglio presso NFlection Therapeutics, Inc.

64 anni

Health Technology

Consumer Services

Posizioni attive di Christopher Powala

Società	Posizione	Inizio	Fine
NFlection Therapeutics, Inc. NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.	Direttore/Membro del Consiglio	-	-
	Amministratore Delegato	-	18/10/2021

Storia della carriera di Christopher Powala

Precedenti posizioni note di Christopher Powala

Società	Posizione	Inizio	Fine
ACLARIS THERAPEUTICS, INC.	Direttore operativo	01/07/2012	01/01/2018
	Fondatore	01/07/2012	03/06/2019
	Corporate Officer/Principal	-	03/06/2019
Vicept Therapeutics, Inc. Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA.	Direttore operativo	05/11/2009	01/07/2011
	Fondatore	01/08/2009	01/07/2011
Vital Therapies, Inc. Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA.	Corporate Officer/Principal	01/05/2008	01/05/2009
CollaGenex Pharmaceuticals, Inc. CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA.	Consigliere Generale	01/01/1993	01/01/2008
Wyeth Laboratories, Inc.	Corporate Officer/Principal	01/01/1985	01/01/1993

Formazione di Christopher Powala

The State University of New York

Undergraduate Degree

Statistiche

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Chief Operating Officer	2
Founder	2

Settori

Health Technology	6
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa	1
ACLARIS THERAPEUTICS, INC.	Health Technology

Aziende private	5
CollaGenex Pharmaceuticals, Inc. CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA.	Health Technology
Vicept Therapeutics, Inc. Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA.	Health Technology
Vital Therapies, Inc. Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA.	Health Technology
Wyeth Laboratories, Inc.
NFlection Therapeutics, Inc. NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.	Health Technology

Vedi le connessioni aziendali